Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-18 Exercise | 2023-02-22 5:41 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer | 3,825 | $0 | 16,547 (Direct) | View |
| 2023-02-21 Tax Withholding | 2023-02-22 5:41 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer | 1,392 | $48.26 | 16,547 (Direct) | View |
| 2022-10-17 Tax Withholding | 2022-10-18 5:38 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer | 1,111 | $55.76 | 13,889 (Direct) | View |
| 2022-10-14 Exercise | 2022-10-18 5:38 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer | 3,750 | $0 | 13,889 (Direct) | View |
| 2022-10-07 Option Award | 2022-10-12 5:42 pm | N/A 2032-10-07 | CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer | 14,000 | $0 | 14,000 (Direct) | View |
| 2022-08-16 Option Award | 2022-08-18 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-22 5:44 pm | N/A 2032-02-18 | CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer | 45,300 | $0 | 45,300 (Direct) | View |
| 2021-10-14 Option Award | 2021-10-18 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2021-04-19 Option Award | 2021-04-20 4:49 pm | N/A 2031-04-18 | Translate Bio Inc. | TBIO | Smith Brendan Chief Financial Officer | 201,800 | $0 | 201,800 (Direct) | View |